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Abstract
Background: Human rhinoviruses (HRVs) are a highly prevalent cause of acute respiratory infection in children. They are
classified into at least three species, HRV-A, HRV-B and HRV-C, which are characterized by sequencing the 59 untranslated
region (UTR) or the VP4/VP2 region of the genome. Given the increased interest for novel HRV strain identification and their
worldwide distribution, we have carried out clinical and molecular diagnosis of HRV strains in a 2-year study of children with
acute respiratory infection visiting one district hospital in Shanghai.
Methodology/Findings: We cloned and sequenced a 924-nt fragment that covered part of the 59UTR and the VP4/VP2
capsid genes. Sixty-four HRV-infected outpatients were diagnosed amongst 827 children with acute low respiratory tract
infection. Two samples were co-infected with HRV-A and HRV-B or HRV-C. By comparative analysis of the VP4/VP2
sequences of the 66 HRVs, we showed a high diversity of strains in HRV-A and HRV-B species, and a prevalence of 51.5% of
strains that belonged to the recently identified HRV-C species. When analyzing a fragment of the 59 UTR, we characterized at
least two subspecies of HRV-C: HRV-Cc, which clustered differently from HRV-A and HRV-B, and HRV-Ca, which resulted from
previous recombination in this region with sequences related to HRV-A. The full-length sequence of one strain of each HRV-
Ca and HRV-Cc subspecies was obtained for comparative analysis. We confirmed the close relationship of their structural
proteins but showed apparent additional recombination events in the 2A gene and 39UTR of the HRV-Ca strain. Double or
triple infections with HRV-C and respiratory syncytial virus and/or bocavirus were diagnosed in 33.3% of the HRV-infected
patients, but no correlation with severity of clinical outcome was observed.
Conclusion: Our study showed a high diversity of HRV strains that cause bronchitis and pneumonia in children. A
predominance of HRV-C over HRV-A and HRV-B was observed, and two subspecies of HRV-C were identified, the diversity of
which seemed to be related to recombination with former HRV-A strains. None of the HRV-C strains appeared to have a
higher clinical impact than HRV-A or HRV-B on respiratory compromise.
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Introduction
Human rhinoviruses (HRVs) are a highly p revalent cause of
theacuterespiratory infection(ARI)definedasthecommon cold
[1,2,3], which is frequently associated in children with
bronchitis, bronchiolitis, wheezing, pneumonia, asthma and
otitis [4,5,6,7,8,9]. HRVs are classified in genus Enterovirus
(HEVs) in family Picornaviridae [10]. HRVs are non-enveloped,
single-stranded, positive-sense RNA viruses of approximately
7200 nt, composed of a 59 untranslated region (UTR), followed
by a long open reading frame coding for capsid proteins VP4,
VP2, VP3 and VP1, and seven non-structural proteins 2A, 2B,
2C, 3A, 3B, 3C and 3D, and terminated by a short 39UTR and
poly A tract.
More than 100 serotypes of HRV are known, which have been
classified into two species, HRV-A and HRV-B, according to
comparative alignment of nucleotide fragments of VP1 [11,12],
VP4/VP2 [13] and 59UTR [14,15], and more recently, on
complete genome nucleotide sequences [16]. Moreover, some
genomic sequences have been found not to cluster with HRV-A
and HRV-B species, which suggests the existence of other species
(HRV-C and HRV-D) [16]. A new species of HRV-C was
recently identified worldwide by comparative analysis of VP4
or VP4/VP2 genes [7,17,18,19,20,21] and 59UTR [14,15].
PLoS ONE | www.plosone.org 1 July 2009 | Volume 4 | Issue 7 | e6355However, discrepancies have appeared in the classification of some
of the new HRV-A or HRV-C strains, depending on the size and
location of the nucleotide sequence in the viral genome and on the
phylogenetic methods used for direct analysis of HRV sequences
[3,7,14,15,17,18,20,21,22,23].
T h e s er e c e n td a t au n d e r l i n et h el a c ko fk n o w l e d g ea b o u tt h e
biodiversity of HRV strains and their worldwide distribution [14,17].
Moreover, little is known about the characteristics and diversity of
HRVs circulating in a given area in a short period of time. In the
present study, we looked for HRVs in a 2-year collection of
nasopharyngeal swabs (NPSs) of children with ARI visiting a district
hospital in Shanghai, and compared sequences in two regions
previously defined for genetic classification of HRV serotypes
[13,15]. Our study showed a high diversity of HRV species and
genotypes, and a prevalence of the novel HRV-C species in NPSs of
children with bronchitis and pneumonia. This biodiversity appeared to
result partly from recombination events in the 59UTR, between HRV-
C strains and those close or similar to HRV-A species, which led to the
suggested classification of HRV-C into at least two subspecies.
Results
Identification and typing by phylogenetic analysis of 66
HRVs in NPSs from children with ARI
Eight hundred and twenty-seven samples were collected from a
group of children consulting the Shanghai Nanxiang Hospital
during a 2-year period, and tested for 17 respiratory viruses using a
multiplex RT-PCR (mRT-PCR). Sixty-four samples (7.7%) were
positive for HRV, according to the length of the amplified
fragment in the VP4/VP2 region visualized on agarose gel (data
not shown). A larger fragment of 924 nt, including part of the
59UTR (starting at nt 163) and the VP4/VP2 genes (ending at nt
1086), was amplified and cloned into plasmid vectors for genetic
analysis (Table 1). Only one sample, N1, could not be amplified
Table 1. Degenerate and specific primers used for RNA amplification from clinical samples.
59–39 Sequence Virus/Gene Start
a End
a Reference
CAAGCACTTCTGTYWCCCC P1-1 F 163 181 [15]
GGGACCAACTACTTTGGGTGTCCGTGT VP4/2 F 528 554 [13]
ACGGACACCCAAAGTAG P3-1 R 536 552 [15]
GCATCIGGYARYTTCCACCACCANCC VP4/2 R 1061 1086 [13]
YCCWCCACARTCWCCWGGTTC 2A R 3488 3508 [12]
TWGCHTTTGAYTACWCNGGNTATGA 3D outer F 6396 6420 [35]
ATGATHGCHTATGGDGAYGAYGT 3D inner F 6668 6690 [35]
GGGTCYYTAGTCCATCTGATTGAYTC 3D inner R 6896 6921 This study
GTAIKGYTCYTCWCCATTGTGCCA 3D outer R 6965 6988 Id
CCGGGGAAACAGAAGTGCTTGAA N4 59race SP2 R 161 183 Id
CTCTGCTTAGTAATTGCGCGGGTA N4 59race SP1 R 228 251 Id
CACCTCTGTGGATAAGCCCACTCAT N4 VP2 outer F 973 997 Id
AGCCCACTCATCCAGAAACATCAG N4 VP2 inner F 987 1010 Id
GGTGAGGGTCCATGTGAACCWGGT N4 2A outer F 3473 3496 Id
GGGTCCATGTGAACCWGGTGACTGT N4 2A inner F 3478 3502 Id
CACGTCATCCCCATATGCGATCA N4 3D inner R 6669 6691 Id
CAATCACGTCATCCCCATATGCGA N4 3D outer R 6672 6695 Id
CTAAATACCCCTTCCTCATTCATCCA N4 3D outer F 6846 6871 Id
CAATCAGATGGACTAGGGACCCAA N4 3D inner F 6900 6923 Id
CCTCGGTGGAAGCCTATTCACACATC N10 59race SP2 R 183 208 Id
GGGTTAAGGTTAGCCACATTCAGGG N10,N13 59race SP1 R 447 471 Id
TGGTGGTGGAARTTACCCGATGC N10,N13 VP2 F 1064 1086 Id
CTGGGTATGAAGCAATCACGTC N10 3D inner R 6686 6707 Id
CTGCTGGGGTTATGGTGAGAC N10 3D outer R 6753 6773 Id
CCAGACACTAAATACCCCTTCCTC N10 3D F 6839 6862 Id
TTTGCCCTGGCGGAGCATATCAGC N13 59race SP2 R 189 212 Id
CCCACATGTGACTGCACTCAAGCA N13 2A outer F 3332 3355 Id
GGTATTACCCAATTAATGTTACCAG N13 2A inner F 3381 3405 Id
GCATATGGGGAYGACGTCRTCTT N13 3D outer F 6674 6696 Id
GCTGGAGTGATTGTAAGACCATA N13 3D R 6749 6771 Id
CAGATGGACTAARGACCCAAT N13 3D inner F 6904 6924 Id
aNucleotide position relative to HRV16.
W=(A/T),H=(A/T/C),D=(G/A/T),Y=(C/T),K=(G/T), R=(A/G),N=(A/G/C/T).
I:Inosine.
Id: this study.
doi:10.1371/journal.pone.0006355.t001
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the VP4/VP2 region (nt 528–1086), respectively. Analyses of
different clones for each sample allowed the identification of
multiple infections: sample N16 was shown to contain one HRV-A
and one HRV-B (N16A and N16B, respectively), while N58
contained one HRV-A and one HRV-C (N58A and N58C,
respectively) (see below). In order to further characterize the 66
HRVs identified in the 64 samples, the nucleotide sequences
located in the 59UTR (285 nt) and the VP4/VP2 genes (420 nt)
were chosen to allow comparative alignment with sequences of
reference serotypes and field strains available in GenBank.
We first compared and classified Shanghai strains according to
their VP4/VP2 sequences. The pairwise nucleotide divergence in
the VP4/VP2 region ranged from 0 to 72.2%. Twenty-seven
HRVs (40.9%) showed .81% nucleotide identity with the closest
HRV-A clusters, and five HRVs (7.6%) showed .88.8%
nucleotide identity with HRV-B clusters (Table 2). The remaining
34 strains (51.5%) diverged from HRV-A and HRV-B species by
.47.3% in their VP4/VP2 nucleotide sequence (Table 2). These
strains showed from 68.3 to 100% nucleotide identity with each
other and were related to the recently described HRV-C strains,
NAT001 and NAT045, isolated in California, USA [18], C024,
C025 and C026 in Hong Kong [20], and QPM in Australia [7,24]
(Fig. 1). Strains N34, N35 and N68 were closely related to the
recently identified strains C025 and NTA001 with .95.9%
nucleotide identity, whereas the 31 remaining HRV-C strains
showed only 74.4–86.4% nucleotide identity with six other recent
strains (QPM, NAT001, NAT045, C024, C025 and C026;
Table 2), which were classified tentatively as HRV-C species
[7,18,20,24]. Classification of the strains into three different
species was also demonstrated by construction of a phylogenetic
tree using aligned VP4/VP2 sequences (Fig. 1).
To characterize and classify further the Chinese HRV strains,
59UTR sequences were considered (Table 3, Fig. 2). They were
compared to the 59 UTR of all 101 reference HRVs, to those of 26
new strains identified in children with respiratory illness in
Wisconsin (indicated as W) [15], and to those of other recently
identified HRV-C strains [14]. Pairwise nucleotide divergence
between the three HRV species was 0.7–64.3%, and a limit of
,9% divergence between genotype pairs was chosen for similar
genotype assignment in one species [15]. New genotypes were
identified when they had 9–30% pairwise nucleotide divergence
from the nearest serotype in the same species (Table 3). Fifty-five
HRVs shared .94.4% nucleotide identity with strains already
identified, and 11 HRVs showed 9.5–20.9% nucleotide divergence
with the nearest known HRVs. They may represent newly
discovered genotypes. These strains clustered with HRV-A (N6)
or HRV-C species (N4, N8, N21, N62, N63, N67, N24, N25, N28
and N32) (Table 3).
Most surprisingly, 20 of the 34 strains classified as HRV-C by
comparative analysis of VP4/P2 sequences (Table 2) were related
more closely to HRV-A strains when their 59UTRs were analyzed,
and showed incongruent clustering in phylogenetic trees (Figs. 1
and 2). The nucleotide sequences in the 59UTR of these strains
were related closely to those of formerly identified QPM,
NAT001, NAT045, C024, C025 and C026 HRV-C strains, and
to some of the W strains recently identified as HRV-A [15] (Fig. 2).
However, our 20 strains clustered together with these six strains in
two major branches in the phylogenetic tree constituted a
subspecies of HRV-C called HRV-Ca (Table 3, Figs. 2 and 3).
The fourteen other HRV-C strains formed another unique branch
of HRV-C subspecies, called HRV-Cc, which clustered differently
from other species of HRV-A and HRV-B, and from subspecies
HRV-Ca in the phylogenetic tree based on 59UTR sequences
(Table 3; Figs. 1 and 2). These strains were related closely to some
W strains of HRV that were classified as HRV-C [15] (Fig. 2,
Table 3)
Recombination in the 59 UTR
In order to characterize more precisely the differences observed
in the 59UTR between HRV-Ca and HRV-Cc subspecies, and to
localize possible recombination sites in the 59UTR of the genome
of HRV-Ca subspecies, bootscanning and similarity plot analyses
were conducted in the gene fragment of 868 nt that included the
59UTR and adjacent capsid genes. HRV-Ca nucleotide sequences
were scanned against sequences of N10, R16 and R52, which are
considered as representative strains of HRV Cc subspecies and
HRV-A and HRV-B species, respectively. Stretches of nucleotide
sequences that were closer to HRV-A (R16) than to HRV-Cc
(N10), flanked by sequences related to HRV-C could be detected
in the 59UTR of HRV-Ca strains, as exemplified with HRV-Ca
N25 strain (Fig. 3a and b). These HRV-A-related nucleotide
stretches were thus flanked by putative recombination sites. These
sites were located differently among the HRV-Ca strains,
delimiting HRV-A-related stretches that ranged from 150 to 400
nt in length (Fig. 3c). While variable among the strains, the
identified recombination sites were all located inside the 59 UTR
and none of them was identified in the downstream VP4/VP2
coding sequence. HRV-A-related nucleotide sequences and
putative recombination sites were also found in the 59UTR of
the previously described HRV-C strains C024, C025, C026,
NAT001, NAT045 and QPM (Fig. 3). The results corroborated
the clustering observed in the phylogenetic tree based on 59UTR
sequences (Fig. 2), since strains gathered in the same HRV-Ca
subcluster (for example N24, N25, N28 and N32, or N4, N7, N8,
N21, N36 and N46) displayed the same recombination pattern.
These subclusters revealed different recombinant lineages, each of
which originated from independent recombination events.
Comparative analysis of full-length genomes of HRV-A,
HRV-B and HRV-C species
In order to further characterize the genome of the HRV-Cc
subspecies, for which no full-length sequence was yet available, we
sequenced the remaining genes that covered the whole coding
sequence and 39UTR of N10 strain, which was chosen as the
representative of this subspecies (Tables 2 and 3). The full-length
N10 genome sequence was compared to those of the HRV-Ca
subspecies strains C024, C025 and C026, and to that of N4 strain,
which was sequenced as the representative of the HRV-Ca
subspecies. The genome sequences were also compared to those of
the HRV-A strains N13 and R44, and to the HRV-B strains R14
and R52 (Table 4). The full-length nucleotide sequence of N10
strain contained 7111 nt, excluding the poly(A) tract, which was
shorter than sequences from HRV-A and HRV-B strains, but
similar to those of HRV-Ca strain N4 and other related strains
(C024, C025 and C026). The 2144 aa lengths of the polyprotein
and of each of the individual proteins of N10 were slightly different
from those of HRV-A and HRV-B species, but similar to those of
other HRV-C strains. The most divergent amino acid length
between HRV was observed for the VP1 protein that was shorter
in HRV-C species (Table 4). The unique putative cleavage (M/S)
site between VP4 and VP2 protein identified previously for QPM,
C024, C025 and C026 strains [20] was also observed for N10 and
N4 strains. It was different from those of the HRV-A strains N13
and R44 (Q/S), and from those of the HRV-B strains R14 and
R52 (N/S) (data not shown).
Alignment of the VP1 amino acid sequence of HRV-Cc strain
N10 with those of other HRV-A and HRV-B species and HRV-Ca
Human Rhinovirus Recombination
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of HRV-C species [16,20,25] (data not shown). In particular,
footprints including deletions in the BC, DE and HI loops and
conserved amino acids potentially involved in Inter-Cellular
Adhesion Molecule 1 (ICAM-1) receptor binding [7,11,20,24] were
conserved within the HRV-C species (data not shown).
Table 2. Characterization of 66 clinical HRV strains in clinical specimens based on partial VP4/VP2 gene sequences.
Clinical HRV strain Nearest Divergence with the Species (subspecies
a)
(% nt identity
b) HRV strain nearest HRV (% nt) classification
N64 Hanks 5.3 A
N14 R98 5.8 A
N31 R23 6.3 A
N3,N16A (98.8) R38 6.5 A
N19 R12 7.7 A
N66 R75 8.5 A
N65 R10 9 A
N23 R22 9 A
N13,N47 (98.6) R47 9.1–9.7 A
N37,N49,N51
c (98.1–99) R58 9.2–10.4 A
N40 R39 9.4 A
N29 R28 9.6 A
N58A R34 10 A
N71 R9 10.2 A
N54 R90 10.2 A
N11,N12,N15
c (99.5–100) R31 10.5 A
N18 R61 11.9 A
N6 R46 15.3 A
N9 R28 18.9 A
N44,N48
c (99.8) R65 22.1–22.4 A
N26 R4 10.1 B
N69 R70 10.2 B
N16B,N17
c (97.4) R37 10.5–11.4 B
N30 R52 12.5 B
N5 NAT045 22.6 C (Cc)
N62,N67
c (99.5) C025 25.3–25.7 C (Cc)
N63 C024 25.6 C (Cc)
N61 NAT045 26.5 C (Cc)
N42,N45
c (99.8) NAT001 29.1–29.4 C (Cc)
N10,N55,N56 (96.5–100) C024,C026 29.9–30.3 C (Cc)
N41 NAT045 30.4 C (Cc)
N43,N50,N58C
c (99–99.8) NAT045 31–31.8 C (Cc)
N35,N68 (96.1) C025 3.0–4.0 C (Ca)
N34 NAT001 3.2 C (Ca)
N22,N33,N38,N39
c (99.3–99.8) C025 15.1–15.8 C (Ca)
N1 C026 20.9 C (Ca)
N24,N25,N28,N32
c (99.5–100) QPM 23.5–24.2 C (Ca)
N27,N52 (96.8) C024,NAT045 28.7–29.1 C (Ca)
N4,N8,N21 (99–99.8) NAT045 29.5–30.5 C (Ca)
N36 QPM 29.7 C (Ca)
N46 NAT001 30.4 C (Ca)
N7 NAT045 31.5 C (Ca)
aSubspecies classification based on local 59UTR sequence variation (See Table 3 and Figs. 1 and 2).
bStrains closely related with more than 96% identity.
cStrains isolated within 3 months.
doi:10.1371/journal.pone.0006355.t002
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genomic sequences of N4 (HRV-Ca), N10 (HRV-Cc), R16 (HRV-
A) and R52 (HRV-B) confirmed that N4 featured a 59UTR
sequence that was related to the R16 sequence (stretch I), followed
by a capsidic sequence related to the N10 sequence. N4 non-
structural sequence (2A to 39UTR) was related more closely to N10
than to R16 and R52 sequences. However, in stretch II (nt 3300–
3500 according to N4 numbering), N4 strain (HRV-Ca) was closer
to R16 (HRV-A) than to R52 (HRV-B) or N10 (HRV-Cc), which
resulted in high bootstrap values between N4 and R16 2A
sequences(Fig. 4).This mayhavebeen the result ofa recombination
event that occurred in the 39 part of the 2A-encoding sequence of
the parental strain N4, and which involved an HRV-A strain.
Nevertheless, the HRV-A parental strain or ancestral strain could
not be identified since the closest HRV-A 2A nucleotide sequence
available was ,80% identical to that of N4 in this region.
In contrast from nt 6,550 to the 39 end (stretch III in Fig. 4), the
N10 strain genome was found to be closely related to that of N4,
with nucleotide identity .98%. This result is corroborated in
Figure 5, which shows a phylogenetic analysis of the 39UTR
sequences of N10 and N4 compared to those of HRV-Ca
subspecies and HRV-A and HRV-B species. This suggests that N4
and N10 strains share a common recent ancestor through
recombination.
Figure 1. Phylogenetic tree depicting relationships between known and novel HRVs based on VP4/VP2 gene analysis. Grouping of
HRV reference serotypes (designated R#), previously published novel HRV strains QPM from Australia (GenBank accession no. E186077), NAT001 and
NAT045 from California (GenBank accession no. EF077237 and EF077281), and C024, C025, and C026 from Hong Kong (GenBank accession no.
EF582385, EF582386, EF582387) designated by a pink triangle, and viral strains detected in our clinical samples designated N# and by open and filled
circles, was based on 420 nt in the VP4/VP2 gene region. Strains fully sequenced in this study are designated by a pink star. HRV-A, HRV-B and HRV-C
are drawn with red, blue and green colors, respectively. Strains classified in HRV-Cc and HRV-Ca subspecies are indicated by filled and open circles,
respectively. Echo 11 and R87 prototypes are included as outgroups. Tree construction and bootstrap values indicated for each major branch in the
tree were determined with PHYLIP package and SEQBOOT, with 1000 replicates.
doi:10.1371/journal.pone.0006355.g001
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Clinical HRV strains Nearest HRV strain Divergence with the species (subspecies)
a
(% nt identity)
b nearest HRV (% nt) classification
N64 R21 1.4 A
N9 W28 1.4 A
N19 R12 1.8 A
N12
c R82 2.1 A
N3,N16A (100) R38 2.2 A
N65 R10 2.5 A
N40 R39 3.2 A
N14 R98 3.3 A
N29 R28 3.3 A
N11,N15 (98.2) R31 3.6–4 A
N37,N49,N51 (99.3–99.7) R58 3.6–4.3 A
N44
c R40 3.7 A
N71 R9 3.7 A
N54 R90 4 A
N66 R75 4 A
N23 R22 4 A
N13,N47 (98.2) R47 4–4.4 A
N18 R61 4.3 A
N48
c W6 4.3 A
N31 R23 4.4 A
N58A R34 5.6 A
N6 R46 9.5 A
N69 R17 1.4 B
N30 R52 2.5 B
N26 R4 3.7 B
N16B R37 4 B
N17 R3 4.8 B
N5 W18 1.1 C (Cc)
N10,N55, N56 (97.8–98.9) W31 0.7–1.1 C (Cc)
N42,N45 (99.3) W37 1.4–2.1 C (Cc)
N41,N43, N50,N58C (93.4–99.7) W32 1.4–5.8 C (Cc)
N61 W26 3.6 C (Cc)
N62,N67 (99.3) W35 10.8–11.7 C (Cc)
N63 W35 20.9 C (Cc)
N7
c W8 0.7 C (Ca)
N1
c W15 1.1 C (Ca)
N34
c NAT001 1.1 C (Ca)
N35,N68
c (97.9) C025 1.4 C (Ca)
N22,N33,N38,N39
c (99–99.7) W23 1.4–2.1 C (Ca)
N27,N52
c (96.2) W10 1.8–4.4 C (Ca)
N36
c W17 1.8 C (Ca)
N46
c W20 2.1 C (Ca)
N24,N25,N28,N32
c (99.6–100) W24 10.6 C (Ca)
N4,N8,N21
c (100) W8 13 C (Ca)
aSubspecies based on phylogenetic analysis (Figs. 1 and 2) and on local recombination in 59UTR (see Fig. 3).
bStrains closely related with more than 93% identity.
cThese strains clustered differently when based on VP4/VP2 sequences (see Table 2 and Figs. 1 and 2).
doi:10.1371/journal.pone.0006355.t003
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outpatients
Among the pediatric patients, 46 were males and 18 females, and
their age ranged from 5 months to 14 years. The majority of HRV
infections were diagnosed between 2 and 6 years of age (84.6%).
Bronchitis(73.4%) and pneumonia (26.6%) were highlyprevalent in
children with comparable incidence in HRV-A and HRV-C
infections (Table 5). Moreover, the ratio of pneumonia over
bronchitis (36.2%) was comparable to that in the whole cohort of
827 children (40.7%). Only one child among the 64 HRV-positive
patients had asthma and was co-infected with HRV-C, influenza A
virus (IAV) and respiratory syncytial virus (RSV) (Table 5), whereas
100 of the 827 patient were diagnosed with asthma. HRVs were
isolated throughout the 2 years, with a predominance of HRV-C
viruses in the cold season (Table 5). Interestingly, different HRV
genotypes were detected within the same period (for example, N1
and N4, N9 and N11/N12, N44/N48 and N51, and N55/N56 and
N62/N67), with a larger diversity and distribution of individual or
paired HRV-A genotypes compared to HRV-C strains, which
clustered in closely-related genotypes (Fig. 2, Tables 2 and 3).
Conversely, N4 and N21 strains of samples collected at 10 months
interval showed 99.8% identity (Fig. 2).
Single HRV infection was diagnosed in 42 children and co-
infections were identified in 22 patients (Table 5), with 17 double
and five triple infections. The viruses most often identified in HRV
co-infection were RSV (six cases) and human bocavirus (HBoV;
four cases), and two patients were co-infected with HRV, HBoV
and RSV (Table 5). There was no difference between HRV-Ca or
HRV-Cc subspecies and any of the clinical or epidemiological
data (data not shown).
Discussion
In this report, we looked for HRVs in a 2-year collection of
NPSs from children with ARI visiting a district hospital in
Figure 2. Phylogenetic tree depicting relationships between known and novel HRVs based on 5’UTR analysis. Grouping of HRV
reference serotypes (designated R#), previously published novel HRV strains (designated by pink triangles), novel strains from Wisconsin [15]
(designated W#), and novel viral strains detected in our clinical samples (designated by N# and circles) was based on 285 nt in the 5’UTR. Strains
fully sequenced in this study are designated by a pink star. See additional legend in Figure 1.
doi:10.1371/journal.pone.0006355.g002
Human Rhinovirus Recombination
PLoS ONE | www.plosone.org 7 July 2009 | Volume 4 | Issue 7 | e6355Shanghai, and found a high diversity of HRV strains that
belonged to different species and genotypes. We characterized by
RT-PCR and sequenced 66 HRVs, among them 27 HRV-A, five
HRV-B, and 34 HRV-C strains. When sequencing the VP4/VP2
region of the HRV genome, several recent studies have identified
new strains of viruses from children and adults with ARI, asthma,
or otitis, which are clustered differently from HRV-A and HRV-B,
and have been classified into a novel HRV-C species
[7,8,17,18,19,20,21,25,26,27,28]. Other groups have also identi-
fied novel HRV-C strains by sequencing the VP1 gene [29] or the
59UTR [14,15] . The different sizes and locations of the regions
amplified in the HRV genomes renders difficult comparative
genetic analysis. Recently, Palmenberg et al. (2009) have finalized
the full-length genome sequences of all HRV-A and HRV-B
reference strains, and identified structural features of these two
species and the novel HRV-C species [16]. In our study, we
identified 34 HRVs (51.5%) that clustered differently from HRV-
A and HRV-B in a phylogenetic tree that was established on the
basis of VP4/VP2 sequences, which were related to recent strains
classified in the novel HRV-C species (Fig. 1, Table 2). Fourteen
HRV-C strains (41.2%) segregated from the other 20 strains
(58.8%) that were closely related to HRV-A in their 59UTR
sequence (Fig. 2). This led us to propose a classification of two
HRV-C subspecies, HRV-Cc and HRV-Ca. In previous studies
Figure 3. Analyses of recombination events in 5’UTR-VP2 partial sequences of HRVs. Bootscanning analysis (A) and pairwise identity (B) of
N25 strain (HRV-Ca) with other strains representative of HRV-A (R16) and HRV-B (R52) species, and HRV-Cc (N10) subspecies. C: Diagram of 5’UTR-VP2
sequences of strains from HRV-Ca subspecies indicating approximate sizes and sites of recombination between HRV-A (red) and HRV-Cc (black) strain
sequences.
doi:10.1371/journal.pone.0006355.g003
Human Rhinovirus Recombination
PLoS ONE | www.plosone.org 8 July 2009 | Volume 4 | Issue 7 | e6355targeting the 59UTR of HRVs, Lee et al. (2007) have identified
nine novel HRVs among 103 HRVs from Wisconsin (19.4%),
which segregated from HRV-A and HRV-B and were classified as
HRV-C [15]. These strains clustered with our field strains within
the HRV-Cc subspecies. Moreover, 17 strains that clustered with
HRV-A, and had 12–35% pairwise nucleotide divergence from
the nearest reference serotype [15], clustered within the two major
branches of HRV-A and HRV-Ca strains (Fig. 3). Therefore, we
cannot ensure that some of the 17 strains were HRV-A or HRV-
Ca strains. Kiang et al. (2008) have identified five novel HRVs out
of 24 clinical samples (20.8%), which segregated from HRV-A and
HRV-B, and were classified as HRV-C, and three additional
strains (12.5%) that also clustered with QPM, C024, C025, C026,
NAT001 and NAT045 [14] (Fig. 2). However, the field HRV
strains of these previous studies were sequenced using a 59UTR
that did not match fully our sequence and that of Lee et al. (2007)
[15], and could not be included in the present study for
comparative analysis. Interestingly, the five strains identified in
California in 2007 [14] and N42 and N45 from our study were
closely related to strain W37 isolated in Wisconsin in the late
1990s [15], and to NAT001 isolated in the winter of 2004 in
California [18], which confirms that similar genotypes of HRV-Ca
are widespread [17].
The strains of HRV-C species identified in the present study
were characterized by analyzing the 59UTR, VP4, and part of
VP2 (Fig. 3). This approach showed the advantages of covering
only 59NCR, VP4/VP2, VP1 or 3D genome fragments. Analyzing
sequences that covered the 59UTR and the downstream VP4/
VP2 capsid region allowed identification of co-infections when
several clones were sequenced, and helped to locate the
recombination sites in strains of the HRV-Ca subspecies. Thus,
this region of the genome may be useful for building a database of
the novel strains that are circulating worldwide.
The genome of HEVs is subject to frequent recombination
[30,31,32,33,34,35,36], with interspecies exchanges observed in
the 59UTR [37]. Palmenberg et al. (2009) have observed
intraspecies recombination in three HRV-A, with structural
characteristics and phylogenetic evidence that suggests a novel
clade D classification [16]. Tapparel et al. (2009) observed
phylogenetic incongruities in 59 UTR, VP1 and 3CD sequences
of two clinical isolates of HRV-A related to recombination [38].
We observed incongruent clustering of N12, N44 and N48 strains
of HRV-A species in the phylogenetic trees based on the 59UTR
or the VP4/VP2 regions of their genomes (Figs. 1 and 2, Table 3),
which suggests intraspecies recombination in the 59UTR.
We observed one co-infection with HRV-A and HRV-B (N16A
and N16B), one with HRV-A and HRV-C (N58A and N58C), and
three co-infections of HRV-A and HRV-B with HEVs that may
favor recombination events. Previous comparison of genome
sequences between 34 HRVs showed only limited recombination
events and a pattern of genetic diversity lower than that observed
with other picornaviruses [25]. The presence in HRV-C
subspecies of sequences that share 90.5–98.6% identity with
HRV-A strains (Table 3) suggests that recombination events
occurred between HRV-C and HRV-A. Bootscanning of the
59UTR of HRV-C strains also showed different sites and lengths
of recombination (Fig. 3c), which suggested that there were several
independent events that led to several groups of HRV-Ca
genotypes, which formed clusters in the phylogenetic tree (Fig. 2).
Comparative analysis of the full-length nucleotide sequences of
two field strains of different HRV-C subspecies (N4 and N10) with
those of other HRV species suggested that multiple interspecies
recombination events occurred in the 59UTR and in the NS2A
protein gene, and that recombination also occurred in the 39UTR
between N4 and a strain close to N10. These findings are in
agreement with those observed for other HEVs, for which
recombination events in the capsid-encoding sequence are very
rare, probably because of structural constraints that restrict the
functioning of chimeric capsids [31]. This result appeals for the
full-length genome sequencing of the major representatives of the
HRV-C species, in order to establish a clear understanding of the
evolution and classification of the novel virus into subspecies.
Comparison of the coding sequences of N10 HRV-Cc with other
strains of HRV-Ca subspecies [20], including our field strain N4,
showed high similarities in the lengths of the 11 proteins, their
cleavage sites, and the structural features of VP1. These
characteristics and the absence of growth in cell culture, noted
in our laboratory and by others (data not shown), support the
classification of the novel strains into a unique HRV-C subspecies.
Our clinical specimens all originated from NPSs from pediatric
outpatients. The remarkable outcome of the study is the large
diversity of genotypes that has circulated in a relatively small group
of people in a district of Shanghai during a 2-year observation.
Although some clusters of similar genotypes in a limited period of
Table 4. Comparative study of HRV genomes and individual proteins.
Strain Species
Genome
length 59 UTR 39UTR ORF Viral proteins No Genbank
(nt) (nt) (nt) (aa)
VP4
(aa)
VP2
(aa)
VP3
(aa)
VP1
(aa)
2A
(aa)
2B
(aa)
2C
(aa)
3A
(aa)
3B
(aa)
3C
(aa)
3D
(aa)
R44 A 7123 612 49 2154 69 266 238 281 142 95 322 77 21 183 460 DQ473499
N13
a A 7136 612 50 2158 69 265 238 286 142 95 322 77 21 183 460 CQ223229
R14 B 7212 628 47 2179 69 262 236 289 146 97 330 85 23 182 460 K02121
R52 B 7216 624 43 2183 69 262 236 293 146 97 330 85 23 182 460 FJ445188
N10
a C 7111 641 43 2143 67 262 235 272 142 99 326 75 22 183 460 CQ223228
N4
a C 7107 619 44 2148 67 262 236 276 142 99 326 75 22 183 460 CQ223227
C024 C 7099 615 52 2144 67 261 235 274 142 99 326 75 22 183 460 EF582385
C025 C 7114 616 42 2152 67 264 239 275 142 99 326 75 22 183 460 EF582386
C026 C 7086 611 49 2142 67 262 233 275 142 97 325 76 22 183 460 EF582387
aStrains of this study.
nt: nucleotides; aa: amino acids; ORF: open reading frame; UTR: untranslated region.
doi:10.1371/journal.pone.0006355.t004
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HRV species and subspecies, and co-infections with two HRV
species were observed. The prevalence of the novel HRV-C in our
specimens (4.1%) differed from previous studies that associated the
prevalence of the novel variant with severe disease outcomes,
which ranged from influenza-like illness or infection of the low
respiratory tract [17,28] to asthma exacerbation, bronchiolitis, and
febrile wheeze [7,8,15,18,20,21,29,39]. All our patients showed
bronchitis or pneumonia, with no etiological correlation with any
of the species or subspecies of HRV. Only one patient co-infected
with HRV-C, IAV and RSV was diagnosed with asthma among
the HRV-positive patients (1.6%), whereas 100 of the 827 children
had asthma (12%). The difference observed with previous studies,
44.6% [8] and 12% [29] asthma in HRV-positive patients, may be
related to the criteria for enrolment. Moreover, none of the
patients in our study were hospitalized, which makes comparison
with hospitalized children difficult [20,24]. Another criterion to
consider in the trend to correlate clinical symptoms with HRV
infection is the presence of co-infecting pathogens. In our study,
four strains of HBoV and six strains of RSV (17.6%) were
identified in association with HRV-C (11.7%). HBoV and RSV
are common viruses diagnosed in ARI, which are often associated
with HRV [40,41], and HBoV was identified in .50% of children
co-infected with HRV [20]. Nevertheless, the incidence of HBoV
in ARI and in severe outcomes remains elusive [42]. More studies
need to be carried out on large numbers of samples from severe
and mild diseases, to identify any obvious role of HRV sequence
diversity and association with other pathogens in disease severity.
Figure 4. Analyses of recombination events in N4 isolate full-length genomic sequence. A: Result of manual bootscanning of N4 genome
against several viruses. B: Pairwise identity of N4 with several viruses. Grey boxes indicate possible recombination sites.
doi:10.1371/journal.pone.0006355.g004
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obvious, we must be aware of the occurrence of novel HRVs that
may become highly virulent.
Materials and Methods
This study was approved by the ethical committee of Shanghai
Nanxiang Hospital and written informed consent was obtained
from the parents of the children.
Specimens and viruses
Clinical specimens (n=827) from NPSs were collected from
children under 14 years old, who experienced a lower respiratory
tract infection, and who were consulting the pediatric department
of Shanghai Nanxiang Hospital during the period October 2006
to October 2008.
Multiplex RT-PCR assay
Total RNA was extracted from NPS specimens using QIAamp
viral RNA Mini Kit (Qiagen, Hilden, Germany), and stored at
280uC. RNA was amplified using the Qiagen One Step RT-PCR
Kit. A five-tube mRT-PCR was used for virus identification as
previously described [43,44]. Tube 1 targeted IAV, influenza B
virus, RSV, and human metapneumovirus; tube 2, parainfluenza
viruses 1 to 4; tube 3, HRV and influenza C virus; tube 4, human
coronaviruses (HCoVs) 229E-HCoV, OC43-HCoV, NL63-
HCoV and HKU1-HCoV; and tube 5, adenovirus and HBoV.
Amplified products were analyzed in 0.5 mg/ml ethidium
bromide/2% agarose gel.
Samples that showed positive results for HRV were amplified
again using specific primers P1-1F and VP4/2R, located in the
59UTR and VP2 gene, respectively (Table 1). One strain of HRV-
C (N1) could not be amplified using the P1 and VP2 extreme
primers and was amplified using primers in 59UTR and VP4/
VP2, respectively (Table 1). In brief, 2.5 ml of extracted RNA was
mixed with 56buffer and 0.4 mM dNTPs, 0.2 mM of each of the
primers, and 1 ml of enzyme mix, and diethylpyrocarbonate-
treated ultrapure water was added to a final volume of 25 ml.
Amplification programs included reverse transcription at 50uC for
30 min, inactivation at 95uC for 15 min, followed by 40 cycles at
94uC for 30 s, 50uC for 30 s, 72uC for 70 s, and final extension at
72uC for 10 min. The amplified DNA products were detected by
ethidium bromide–agarose gel electrophoresis. The lengths of P1-
VP2, VP4-VP2 and P1-P3 amplicons were 924, 559 and 390 nt,
respectively. DNA products were extracted from agarose gels by
using QIAquick Gel Extraction Kit (Qiagen), and were ligated into
pMD20-T vector (Takara Biotechnology, Dalian, China), and at
least two recombinant plasmids were sequenced in Biosune
Sequence Company and Life Biotechnology in Shanghai, China.
Sequences of different clones of N16 and N58 showed identities for
either HRV-A or HRV-B strains. More plasmids were sequenced
for these strains to confirm that the two patients were originally co-
infected with two different HRV species.
Complete genome sequencing
Sequences of three complete genomes of HRV were obtained
for strains N4 (reference R3061207002 collected on December 7,
2006), N10 (R3070614001 collected on June 14, 2007) and N13
(R3070719007 collected on July 19 2007). Primers used for the
amplification of viral genomes were designed after multiple
alignments of sequences from the genomes of different HRVs
available in GenBank (Table 1). Overlapping amplified DNA
products were obtained after PCR of cDNA that was obtained
using oligodT and a Transcriptor High Fidelity cDNA Synthesis
Kit (Roche, Mannheim, Germany), following the manufacturer’s
protocols. Briefly, 10.4 ml viral RNA was mixed with 1 ml oligodT
and heated at 65uC for 10 min, and then kept on ice for 2 min.
After addition of 4 ml5 6buffer, 0.5 ml Protector RNase Inhibitor,
Figure 5. Phylogenetic tree based on the 3’ terminal part of the
viral genomes (nt 6650 to end, according to N4 numbering).
Dark triangles represent HRV-A and HRV-B sequences clustering
together.
doi:10.1371/journal.pone.0006355.g005
Table 5. Clinical seasonal, and virological characteristics by
HRV group.
HRV species
AB CA +B
a A+C
b
Number of cases 25 4 33 1 1
Symptoms
Bronchitis 18 2 26 1
Pneumonia 7 2 7 1
Season
Spring 3 0 7 1
Summer 9 1 4
Autumn 6 3 7 1
Winter 7 0 15
Single Infection 19 1 22
Co-infection 6 3 11 1 1
PIV1 2 1
ADV 1 2(1
c)
BoV 2 4(2
c)
RSV 1 6(5
c)1
c
HEV 1 2
HMPV 1
IAV 1
c
aPatient co-infected by two HRV-A and HRV-B strains, and RSV.
bPatient co-infected by HRV-A and HRV-C strains, and PIV1.
cCases with triple infection : RSV/IAV/HRV-C, RSV/ADV/HRV-C.
RSV/BoV/HRV-C, RSV/BoV/HRV-AC, RSV/HRV-A/HRV-B.
doi:10.1371/journal.pone.0006355.t005
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incubated at 50uC for 1 h, inactivated at 85uC for 5 min, and
stored at 220uC.
Amplification of a 3D region of N4, N10 and N13 HRV strains
was carried out by nested-PCR using Takara EXTaq (Takara
Biotechnology) and specific primers (Table 1), for 35 cycles of 30 s
at 94uC, 30 s at 55uC, and 70 s at 72uC. To amplify VP1
(upstream of 2A) sequences of N4 and N13 strains, nested PCR
was carried out using Takara LATaq with GC buffer I(Takara
Biotechnology), specific primers (Table 1), and incubation for 35
cycles of 30 s at 94uC, 30 s at 60uC, and 4 min at 68uC. The
fragment VP2–3D of N10 HRV strain was obtained by semi-
nested PCR and specific primers VP2 F, and 3D inner and outer
reverse primers (Table 1), using Takara LATaq with GC buffer II,
for 35 cycles of 30 s at 94uC, 30 s at 60uC, and 6 min at 68uC.
The terminal part of the whole genome was obtained by rapid
amplification of cDNA ends using 59/39 rapid amplification of the
cDNA kit, following the manufacturer’s protocol (Roche). To
perform 59 terminal RACE, 4 mlo f5 6cDNA buffer, 2 ml dNTPs,
1.25 ml specific primer 1 (10 mM), 9.2 ml RNA, 1 ml control
primer neo1/rev (12.5 mM), 1 ml control RNA, 1 ml RT enzyme,
and 0.6 ml RNase inhibitor (Roche) were mixed and incubated for
55uC for 60 min, followed by inactivation at 85uC for 5 min, and
stored on ice. The product was purified using the Qiagen PCR
Purification Kit and eluted with 30 ml deionized distilled water. A
polyA tail was added to the cDNA, by mixing 9.5 ml DNA with
1.25 ml1 0 6 reaction buffer, 1.25 ml (2 mM) dATP, and after
incubation at 95uC for 3 min, the reaction was chilled on ice for
2 min. After addition of 0.5 ml terminal transferase, the reaction
was incubated at 37uC for 30 min, inactivated at 70uC for 10 min,
and kept on ice. Nested PCR was performed by using the Expend
High Fidelity PCR kit (Roche). A mixture of 2.5 ml poly-dA-tailed
cDNA, 0.5 ml oligodT-anchor primer 37.5 mM, 0.62 ml SP2
primers (10 mM) (Table 1), 0.5 ml control neo2/rev primer
(12.5 mM), 0.5 ml dNTP, 0.35 ml enzyme, 2.5 ml1 0 6 buffer,
and 18 ml ddH2O was incubated for 40 cycles of 30 s at 94uC, 30 s
at 60uC, and 30 s at 72uC. To perform 39 terminal RACE, the
method was similar to normal two-step RT-PCR using 3D inner
and outer F primers (Table 1).
Sequence alignment, phylogenetic analyses and
recombination analysis
DNA sequences used for P1-P2 gene analysis were based on
HRV-16 nt 178–462 and those used for VP4/VP2 gene analysis
were based on HRV-16 nt 626–1045. Multiple sequences were
aligned using Clustal X [45]. The multiple-sequence alignment
was subjected to phylogenetic analyses using programs in the
PHYLIP package (v3.6). Bootstrap analysis was performed using
SEQBOOT, with a replicate number of 1000. Then, DNADIST
and NEIGHBOR were used to obtain distance matrices with the
F84 parameter, and a transition/transversion ratio of 4. Consensus
trees were computed by CONSENSE, and then re-rooted with
RETREE. The final tree was visualized and edited with MEGA
version 4 [46].
Recombination analysis was carried out by using Recombina-
tion Detection Program v.3.22. Manual bootscanning was
performed by using the Juke-Cantor algorithm and the neigh-
bor-joining method [47], with a window size of 200 nt, a step size
of 20 nt and 100 replicates. Pairwise identities between sequences
were determined with SimPlot software method [48],with a
window size of 200 nt and a step size of 20 nt. Pairwise homology
matrices were obtained by using CLC Combined Workbench 3.0
software (CLC bio, Aarhus, Denmark).
Nucleotide sequence accession numbers
The original P1-VP2 sequences described in this study were
deposited in GenBank under accession nos. GQ223119 to
GQ223136. The VP4-VP2 sequences were deposited under the
nos GQ223137 to GQ223181, and the P1-P2 sequences under the
nos GQ223182 to GQ223226. The full length genomes sequences
of N4, N10 and N13 strains were deposited under the nos.
GQ223227, GQ223228, GQ223229, respectively.
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